On International Men's Day, the Clinical Trials Arena team investigates three therapies being investigated in prostate cancer ...

He further noted that active surveillance is generally recommended for patients diagnosed with early-stage, low-grade ...

Prostate cancer can be classified as the second most common and lethal cancer among men on the planet after skin cancer.

The completion of enrollment of the SOLAR-RECUR trial is yet another significant milestone for Curium. Cu 64 PSMA I&T represents an important pillar in the development of our theranostic program for ...

Janux Therapeutics' innovative cancer treatment shows promise in reducing side effects and improving patient outcomes, but ...

Bayer HealthCare provided support for this research. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or ...

When conversations about cancer arise, common narratives often centre on breast, lung, or colon cancer. While these deserve their spotlight, prostate cancer ...

We all have a unique face, fingerprint, voice and signature, so why wouldn’t we have a unique response to the medicine and ...

Evan Saugstad, former mayor of Chetwynd, a columnist with Energerticcity.ca, and a cancer survivor, joined Steve Berard on ...

By therapy, external beam radiotherapy is projected to lead the segment and is estimated to grow with a CAGR of 7.9% during ...

Although September is known as Prostate Cancer Awareness Month, I have chosen to tell my prostate journey for Movember, Men’s ...

If you are planning a pregnancy, you need to focus on your health as well as your partner’s. Your man also needs to look ...